Delivery Order SPE2DB25D9320-SPE2DB25FWFCZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count packages). This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply...
- On August 7, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569023499, is for 60 tablets of Xtandi 80 mg, an oncology medication. This award was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025. The order represents a single delivery under DMS...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription oncology medication. This delivery order, awarded on September 12, 2025, with completion targeted for September 15, 2025, represents a direct pharmaceutical supply fulfillment to support Department of Defense healthcare operations. The award carries no set-aside designation, and DMS Pharmaceutical Group Inc., a woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- On September 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, designated as Contract Number 4569422161, calls for the supply of Xtandi 40 mg capsules in a quantity of 120 units. This award represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was issued without a...
- The Defense Logistics Agency awarded a $4,169.59 delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, designated 4569340914, is scheduled for completion by September 8, 2025, and will be performed at the vendor's facility in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription medication used in oncology treatment. The contract, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,683.02 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count units), an oncology medication used in cancer treatment, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, allowing the...
- On September 16, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order (4569478146) is for 120 tablets of Xtandi 40 mg, an oncology medication, with an ultimate completion date of September 17, 2025. This award was issued without a set-aside designation, leveraging DMS Pharmaceutical Group's competitive capabilities...
- On August 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 120 capsules of Xtandi 40 mg, an oncology treatment medication, under a firm fixed-price contract with an ultimate completion date of August 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFCZDelivery Order
On September 16, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, an oral medication used in oncology treatment. This firm fixed-price delivery order, issued without a set-aside designation, represents a single issuance under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The performance location is Park Ridge, Illinois, with an ultimate completion date of September 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The company holds a critical position within the federal pharmaceutical supply chain, supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. This delivery order exemplifies DMS Pharmaceutical Group's core business of distributing specialized pharmaceutical products to military and federal healthcare systems through the Defense Logistics Agency's pharmaceutical supply program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/16/25 |